Lupin announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried out at its Aurangabad manufacturing facility. The inspection was carried out from 06 May to 15 May 2019. The inspection at the Aurangabad facility closed with three observations. The Company is confident of addressing them satisfactorily.
Powered by Capital Market - Live News